John N. Gitonga

Immunology/arboviruses/vaccines/One health

[Medical Sciences @OxfordMedSci]

NEWS: First volunteers receive Rift Valley fever vaccine in Kenya Phase II trial

Researchers at @KEMRI_Wellcome Trust Research Programme have begun the most advanced stage of testing for vaccines, providing volunteers with the ChAdOx1 RVF.

https://t.co/BCrScMt9gw

[John N. Gitonga @Njuejgitonga]

@TimoChege @grk2599 Congratulations

[John N. Gitonga @Njuejgitonga]

@AIRTEL_KE your network is very poor in Kilifi, Kindly work on it.

[John N. Gitonga @Njuejgitonga]

@KUCCPS_Official When are you going to announce placement results for 2022 candidates

[John N. Gitonga @Njuejgitonga]

@KUCCPS_Official The site is super slow. With this speed many students may not be able to choose their courses within the given time

[KEMRI-Wellcome @KEMRI_Wellcome]

A team led by Prof @George_Warimwe reports promising results from a Phase 1 trial of ChAdOx1 vaccine against Rift Valley fever which shows that it is safe and immunogenic in humans.
Read the full report here : https://t.co/ZWtt6eWNwN

[James Nyagwange @JNyagwange]

Serum IgG and mucosal IgA antibodies from pre-pandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro https://t.co/cpyOF0gGGo

[John N. Gitonga @Njuejgitonga]

Many congratulations @George_Warimwe

[KEMRI-Wellcome @KEMRI_Wellcome]

Congratulations to @George_Warimwe for being conferred the title full Professor in Vaccinology at the University of Oxford @UniofOxford. "I’m truly honoured by this recognition. It is testimony to the excellent mentorship received over the years and the immense contribution to...

[John N. Gitonga @Njuejgitonga]

@WCIPGLASGOW @rowlandos @UofGlasgow @KEMRI_Wellcome @PhilipBejon @UofGDeanGlobal @jimbrewer84 @UofGVC @RachelSandison @IDeAL_KEMRI_WT @Hammarton_lab @AndrewPWaters Congratulations Daktari!!

[John N. Gitonga @Njuejgitonga]

@sam_skmuchina @amulele_anne @jayberkley @IDeAL_KEMRI_WT @KEMRI_Wellcome Congratulations

[John N. Gitonga @Njuejgitonga]

@Jonathan_Abuga @crjnewton @sam_skmuchina @symonmkariuki Congratulations Daktari!!

[John N. Gitonga @Njuejgitonga]

@Toinoti @George_Warimwe @PhilipBejon @SassyMolyneux @EYE_Strategy @wellcometrust @MSFsci @EDCTP @KEMRI_Wellcome Congratulations Daktari!!

[John N. Gitonga @Njuejgitonga]

@sam_skmuchina @kenniajin @FaithOsier @eustasius @IDeAL_KEMRI_WT @SSACABDeltas @TibaPartnership Congratulations Daktari

[Philip Bejon @PhilipBejon]

Paper on COVID PCR testing in Kenya. 92% of PCR +ve people were asymptomatic. Partly about use of tests - testing dominated by mass screening and travellers - but also shows how very common asymptomatic infection is in Kenya. https://t.co/tyk06Gw1E4

[John N. Gitonga @Njuejgitonga]

@AIRTEL_KE Sounds like there is no urgency on sorting out issues. Not even making a call, I think you people need to be a little bit serious on addressing issues.

[John N. Gitonga @Njuejgitonga]

@AIRTEL_KE please attend to my ticket.. Ticket ID 210122264508
My airtel line is useless since yesterday, I cannot make calls and Internet connectivity is also not working.

[James Nyagwange @JNyagwange]

Compared our In-house KWTRP ELISA to WHO recommended Wantai ELISA. It performed as well, even better specificity.
https://t.co/54ZzKLwRfD

[Shaban Mwangi 🇰🇪 @MwangiShaban]

What a thumping win!

[John N. Gitonga @Njuejgitonga]

Congratulations @IOyier and @DKamuya

[KEMRI-Wellcome @KEMRI_Wellcome]

Congratulations to our Head of Bioscience @IOyier & Head of Health Systems @DKamuya on their conferment of tittle of Associate Professorship by @NDMOxford. In recognition of contributions to research, teaching and administration at Oxford & beyond. @KEMRI_Kenya @IDeAL_KEMRI_WT

[KEMRI-Wellcome @KEMRI_Wellcome]

In this article, @Toinoti talks about research on safety & efficacy of using fractional doses of yellow fever vaccine; they induce similar immunologic protection as standard doses

https://t.co/dZGhyE69SJ

@EYE_Strategy @wellcometrust @MSFsci
@EDCTP @PhilipBejon @George_Warimwe